# Phase 2 brain cancer trials recruiting: 84 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 84 trials in phase 2 for brain cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 brain cancer trials: 84 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/brain-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 84
- Recruiting or not yet: 84
- Read on: November 19, 2026

## Trials

The 25 newest of 84, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07916389 | Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric Glioma | St. Jude Children's Research Hospital | Phase 2 | Not yet recruiting | Infant-Type Hemispheric Glioma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916389) |
| October 29, 2026 | NCT07903051 | Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing Surgery | Beijing Tiantan Hospital | Phase 2 | Not yet recruiting | Brain Neoplasms, Sleep Initiation and Maintenance Disorders | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903051) |
| October 23, 2026 | NCT07893197 | Ceritinib Treatment for Recurrent Meningiomas | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Recurrent Meningioma, Grade I and Grade II | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893197) |
| October 22, 2026 | NCT07888647 | IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas | German Cancer Research Center | Phase 2 | Not yet recruiting | Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4 | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888647) |
| July 7, 2026 | NCT07688356 | Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors | Samsung Medical Center | Phase 2 | Recruiting | Primary Brain Tumor, Metastatic Brain Tumor | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07688356) |
| July 2, 2026 | NCT07680439 | Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). | BrainChild Bio, Inc | Phase 2 | Recruiting | Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor, CNS Tumor, Central Nervous System Tumor, Pediatric Cancer, Adult... | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680439) |
| June 3, 2026 | NCT07623577 | Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases | Fudan University | Phase 2 | Recruiting | TNBC, Brain Metastasis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623577) |
| April 20, 2026 | NCT07539753 | Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases | Nanfang Hospital, Southern Medical University | Phase 2 | Not yet recruiting | Breast Cancer, Brain Metastases, HR+/HER2- Breast Cancer | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07539753) |
| April 1, 2026 | NCT07505979 | SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases | National Taiwan University Hospital | Phase 2 | Not yet recruiting | Brain Metastases From Solid Tumors | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07505979) |
| March 25, 2026 | NCT07492680 | A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic... | Bristol-Myers Squibb | Phase 2 | Recruiting | Solid Tumors | 254 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07492680) |
| March 13, 2026 | NCT07470606 | Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain | The University of Texas Health Science Center at San Antonio | Phase 2 | Recruiting | Brain Tumor | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07470606) |
| March 10, 2026 | NCT07462507 | Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using \[C-11\]-CS1P1 | Washington University School of Medicine | Phase 2 | Recruiting | Central Nervous System Cancer, Brain Metastases | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07462507) |
| March 9, 2026 | NCT07458113 | Sac-TMT for Active TNBC Brain Metastases | Yale University | Phase 2 | Not yet recruiting | Metastatic Triple Negative Breast Cancers | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07458113) |
| February 27, 2026 | NCT07439172 | Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. | Cooper Norcross Health | Phase 2 | Recruiting | High Grade Gliomas, Glioblastoma, Astrocytoma, Oligodendroglioma | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07439172) |
| February 24, 2026 | NCT07428616 | A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma | Exelixis | Phase 2 | Recruiting | Meningioma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07428616) |
| February 11, 2026 | NCT07402343 | Tarlatamab for SCLC Brain Metastases | Maastricht University Medical Center | Phase 2 | Recruiting | Small Cell Lung Cancer, Brain Metastases, Adult | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07402343) |
| February 3, 2026 | NCT07383649 | Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection | The Methodist Hospital Research Institute | Phase 2 | Recruiting | Brain Cancer Metastatic, CMV Viremia | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07383649) |
| January 26, 2026 | NCT07365410 | Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study | Tianjin Medical University Cancer Institute and Hospital | Phase 2 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC), Brain Metastases, Furmonertinib, EGFR Mutation | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07365410) |
| January 15, 2026 | NCT07343479 | Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases | Zhejiang Cancer Hospital | Phase 2 | Not yet recruiting | NSCLC (Advanced Non-small Cell Lung Cancer), EGFR Gene Mutations, Brain Metastasis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07343479) |
| January 8, 2026 | NCT07326566 | Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII | Black Diamond Therapeutics, Inc. | Phase 2 | Recruiting | Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM, Glioblastoma Multiforme (GBM), Glioma, Central Nervous System... | 162 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07326566) |
| December 22, 2025 | NCT07297212 | A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent... | BioNTech SE | Phase 2 | Recruiting | Recurrent Glioblastoma | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07297212) |
| November 25, 2025 | NCT07248228 | Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial) | Case Comprehensive Cancer Center | Phase 2 | Recruiting | Brain Metastases | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07248228) |
| November 12, 2025 | NCT07227610 | Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT) | Medical University of South Carolina | Phase 2 | Recruiting | Brain Metastases, Cancer (With CNS Involvement) | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07227610) |
| October 3, 2025 | NCT07206849 | Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) | Nationwide Children's Hospital | Phase 2 | Not yet recruiting | High Grade Glioma (HGG) of the Brain With BRAF Aberration, High Grade Glioma (III or IV), Diffuse Intrinsic Pontine... | 79 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07206849) |
| September 29, 2025 | NCT07197008 | Sacituzumab Tirumotecan (Sac-TMT) Plus Bevacizumab in 3rd Generation EGFR-TKI Treated Advanced EGFR-mutant Nonsquamous NSCLC With Brain... | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Lung Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07197008) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| M.D. Anderson Cancer Center | 6 |
| Fudan University | 3 |
| Nationwide Children's Hospital | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Mayo Clinic | 2 |
| St. Jude Children's Research Hospital | 2 |
| Baptist Health South Florida | 2 |
| Massachusetts General Hospital | 2 |
| Maastricht University Medical Center | 2 |
| Case Comprehensive Cancer Center | 2 |
| National Taiwan University Hospital | 1 |
| Northwell Health | 1 |
| The University of Texas Health Science Center at San Antonio | 1 |
| Beijing Tiantan Hospital | 1 |
| University of Zurich | 1 |
| University Health Network, Toronto | 1 |
| Brigham and Women's Hospital | 1 |
| German Cancer Research Center | 1 |
| [BioNTech SE](https://specstream.ai/data/clinical-trials/company/biontech-se) | 1 |
| Yale University | 1 |
| Stanford University | 1 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 1 |
| Biostar Pharma, Inc. | 1 |
| Wake Forest University Health Sciences | 1 |
| Washington University School of Medicine | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 50 |
| China | 12 |
| Canada | 6 |
| Germany | 5 |
| Spain | 4 |
| Australia | 4 |
| United Kingdom | 4 |
| France | 3 |
| Netherlands | 3 |
| Italy | 2 |
| Norway | 2 |
| South Korea | 2 |
| New Zealand | 2 |
| Switzerland | 1 |
| Belgium | 1 |
| Hong Kong | 1 |
| Ireland | 1 |
| Japan | 1 |
| Sweden | 1 |
| Denmark | 1 |
| Austria | 1 |
| Brazil | 1 |
| Hungary | 1 |
| Russia | 1 |
| Singapore | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Geriatric medicine practices in the United States](https://specstream.ai/data/businesses/geriatric-medicine-practices/united-states)
- [Immigration law firms in the United States](https://specstream.ai/data/businesses/immigration-law-firms/united-states)
- [Lawn care companies in the United States](https://specstream.ai/data/businesses/lawn-care-companies/united-states)
- [Moroccan restaurants in the United States](https://specstream.ai/data/businesses/moroccan-restaurants/united-states)
- [Pediatric dentistry practices in the United States](https://specstream.ai/data/businesses/pediatric-dentistry-practices/united-states)
- [Psychiatric hospitals in the United States](https://specstream.ai/data/businesses/psychiatric-hospitals/united-states)
